Matches in SemOpenAlex for { <https://semopenalex.org/work/W2015303096> ?p ?o ?g. }
- W2015303096 endingPage "955" @default.
- W2015303096 startingPage "948" @default.
- W2015303096 abstract "Aberrant reactivation of hedgehog (Hh) signaling has been described in a wide variety of human cancers and in cancer stem cells. However, the contribution of Hh signaling to leukemic cell regulation has remained unclear. In this study, we assessed the possibility that Hh pathway activation contributes to the survival and drug resistance of cluster of differentiation (CD)34 + leukemia cells. Hh signaling in leukemic cell lines and primary leukemic cells was screened by reverse transcription – polymerase chain reaction (RT‐PCR) and a Hh signaling reporter assay. We found that Hh signaling is active in several human acute myeloid leukemia (AML) cells, especially primary CD34 + leukemic cells and cytokine‐responsive CD34+ cell lines such as Kasumi‐1, Kasumi‐3 and TF‐1. These CD34+ cells express the downstream effectors glioma‐associated oncogene homolog (GLI)1 or GLI2, indicative of active Hh signaling. Moreover, inhibition of Hh signaling with the naturally derived Smoothened antagonist cyclopamine, endogenous Hh inhibitor hedgehog‐interacting protein or anti‐hedgehog neutralizing antibody induced apoptosis after 48 h of exposure, although these CD34 + cell lines exhibited resistance to cytarabine (Ara‐C). In contrast, cyclopamine failed to affect growth or survival in U937 and HL‐60 cell lines that lack expression of Hh receptor components, confirming that the effect of Hh inhibition is specific. Furthermore, combination with 10 µM cyclopamine significantly reduced drug resistance of CD34 + cell lines and primary CD34 + leukemic cells to Ara‐C. These results suggest that aberrant Hh pathway activation is a feature of some CD34 + myeloid leukemic cells and Hh inhibitors may have a therapeutic role in the treatment of AML. ( Cancer Sci 2009; 100: 948–955)" @default.
- W2015303096 created "2016-06-24" @default.
- W2015303096 creator A5000591714 @default.
- W2015303096 creator A5008694549 @default.
- W2015303096 creator A5018767527 @default.
- W2015303096 creator A5019959563 @default.
- W2015303096 creator A5021158752 @default.
- W2015303096 creator A5022193625 @default.
- W2015303096 creator A5042912300 @default.
- W2015303096 creator A5054498346 @default.
- W2015303096 creator A5055363992 @default.
- W2015303096 creator A5074930047 @default.
- W2015303096 creator A5087008302 @default.
- W2015303096 date "2009-04-16" @default.
- W2015303096 modified "2023-10-15" @default.
- W2015303096 title "Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells" @default.
- W2015303096 cites W1528295994 @default.
- W2015303096 cites W1563053828 @default.
- W2015303096 cites W1596473475 @default.
- W2015303096 cites W1676048097 @default.
- W2015303096 cites W1944656442 @default.
- W2015303096 cites W1966043852 @default.
- W2015303096 cites W1972332158 @default.
- W2015303096 cites W1976550012 @default.
- W2015303096 cites W1977688398 @default.
- W2015303096 cites W1986820364 @default.
- W2015303096 cites W1994013203 @default.
- W2015303096 cites W1995511594 @default.
- W2015303096 cites W1997379399 @default.
- W2015303096 cites W1997905438 @default.
- W2015303096 cites W2010547317 @default.
- W2015303096 cites W2012526118 @default.
- W2015303096 cites W2021354108 @default.
- W2015303096 cites W2026889598 @default.
- W2015303096 cites W2033393931 @default.
- W2015303096 cites W2044845092 @default.
- W2015303096 cites W2052767351 @default.
- W2015303096 cites W2055296003 @default.
- W2015303096 cites W2059022111 @default.
- W2015303096 cites W2067761409 @default.
- W2015303096 cites W2077439507 @default.
- W2015303096 cites W2090542192 @default.
- W2015303096 cites W2099801494 @default.
- W2015303096 cites W2101365524 @default.
- W2015303096 cites W2103598783 @default.
- W2015303096 cites W2109515409 @default.
- W2015303096 cites W2116666381 @default.
- W2015303096 cites W2122700044 @default.
- W2015303096 cites W2125923072 @default.
- W2015303096 cites W2126148147 @default.
- W2015303096 cites W2127409621 @default.
- W2015303096 cites W2128341240 @default.
- W2015303096 cites W2131301194 @default.
- W2015303096 cites W2133117291 @default.
- W2015303096 cites W2137715553 @default.
- W2015303096 cites W2139071981 @default.
- W2015303096 cites W2144486277 @default.
- W2015303096 cites W2146196731 @default.
- W2015303096 cites W2151041687 @default.
- W2015303096 cites W2151907359 @default.
- W2015303096 cites W2153889566 @default.
- W2015303096 cites W2161045200 @default.
- W2015303096 cites W2171203391 @default.
- W2015303096 doi "https://doi.org/10.1111/j.1349-7006.2009.01111.x" @default.
- W2015303096 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19245435" @default.
- W2015303096 hasPublicationYear "2009" @default.
- W2015303096 type Work @default.
- W2015303096 sameAs 2015303096 @default.
- W2015303096 citedByCount "115" @default.
- W2015303096 countsByYear W20153030962012 @default.
- W2015303096 countsByYear W20153030962013 @default.
- W2015303096 countsByYear W20153030962014 @default.
- W2015303096 countsByYear W20153030962015 @default.
- W2015303096 countsByYear W20153030962016 @default.
- W2015303096 countsByYear W20153030962017 @default.
- W2015303096 countsByYear W20153030962018 @default.
- W2015303096 countsByYear W20153030962019 @default.
- W2015303096 countsByYear W20153030962020 @default.
- W2015303096 countsByYear W20153030962021 @default.
- W2015303096 countsByYear W20153030962022 @default.
- W2015303096 countsByYear W20153030962023 @default.
- W2015303096 crossrefType "journal-article" @default.
- W2015303096 hasAuthorship W2015303096A5000591714 @default.
- W2015303096 hasAuthorship W2015303096A5008694549 @default.
- W2015303096 hasAuthorship W2015303096A5018767527 @default.
- W2015303096 hasAuthorship W2015303096A5019959563 @default.
- W2015303096 hasAuthorship W2015303096A5021158752 @default.
- W2015303096 hasAuthorship W2015303096A5022193625 @default.
- W2015303096 hasAuthorship W2015303096A5042912300 @default.
- W2015303096 hasAuthorship W2015303096A5054498346 @default.
- W2015303096 hasAuthorship W2015303096A5055363992 @default.
- W2015303096 hasAuthorship W2015303096A5074930047 @default.
- W2015303096 hasAuthorship W2015303096A5087008302 @default.
- W2015303096 hasConcept C10205521 @default.
- W2015303096 hasConcept C145837895 @default.
- W2015303096 hasConcept C185592680 @default.
- W2015303096 hasConcept C203014093 @default.
- W2015303096 hasConcept C2777605378 @default.